Home > PORTAL > about Us > Presentation >
Discover the services provided by SPIN’s website
How does www.spindermatology.org work?
The SPIN website offers you several services:
>> World Directory of Psoriasis Medial Resources
An interactive map listing dermatology centres specialised in the management of psoriasis. For each centre listed in this directory, you can see which medical resources they provide to psoriasis patients: available treatments, dedicated inpatient/outpatient facilities, interdisciplinary consultations, clinical trials, collaboration with patient associations.
For each centre, you can learn how to get an appointment, and you have access to the postal address and contact information.
>> World Directory of Atopic Dermatitis Medial Resources (coming soon!)
>> PIN News
Each member of the network can contribute with articles, events, works, etc., as long as the documents are provided in English. In this section, you will find:
- Our "Focus On" on major works or events of the network or special showcases of our partner medical groups or patient associations; also, you will find the latest news published in our website
- The news from the weboffice provides general information on SPIN activities
- In the events tab you will find a list of national and international events such as conferences, meetings, World Psoriasis Day...
- The news from medical groups showcasing the works shared by the national groups
- The news from patient associations presenting the latest activities of our partner associations
- The recent publications on psoriasis lists the latest Pumed articles on psoriasis and atopic dermatitis
When you wish to share information with the SPIN community, please send it in English to our weboffice. We will then post your news in the news section.
>> Running Projects
In this section you will find all the relevant information about SPIN’s ongoing projects and activities.
>> The Country Sites section
This section fosters the websites of national medical groups and of patient associations. Also, it allows those groups or associations that don’t have a website of their own, to create one for free. To proceed to the creation of your own website, please visit the "Country Sites" section and follow the instructions.
The national websites give you general information about the countries which are part of the network and it aims at:
- Fostering connections in each country between dermatologists and patients,
- Making easier to share information and to engage collaborations between countries.
To design and manage your own website, please use the website management tool.
>> The Website Management Tool
The website management tool is designed for your national medical group or for your patient association. This tool will guide you to build a website in your national language or to create a link with your pre-existent website. To use this section, you need to register. Please go to the website management tool at the bottom right of the homepage.
If you have any question, please, do no hesitate to contact our weboffice.
>> The International Links section
This section provides you links to other international psoriasis and atopic dermatitis organisations.
>> The Keywords section
This section gives you general information about psoriasis. It is a glossary with direct links to Pubmed’s main publications on psoriasis. A similar glossary for atopic dermatitis is to be developed soon.
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Uncovering the mechanism of Jueyin granules in the treatment of psoriasis using network pharmacology.
J Ethnopharmacol.
2020 Nov 15, 262:113214.
Our clinical practice demonstrated that Jueyin granules (JYG) benefit patients with mild to moderate psoriasis vulgaris without apparent adverse effects. JYG have been shown to inhibit epidermal proliferation in an imiquimod (IMQ)-induced psoriasis-like mouse model, as well as keratinocyte proliferation. Moreover, JYG causes no acute or chronic toxicity in animal models. However, its related molecular mechanism has still not been (...)
see on pubmed
Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
Drug Deliv.
2020 Dec , 27, (1):662-680.
Psoriasis is a dermatological chronic skin condition with underlying autoimmune etiology. It deeply affects patients' quality of life. Therefore, it was an interesting target for researchers throughout the past years. Conventionally, the treatment options include anti-inflammatory agents, immune suppressants, biologic treatment, and phototherapy. Nanotechnology offers promising characteristics that allow for tailoring a drug carrier to achieve dermal targeting, improved efficacy and (...)
see on pubmed
In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors.
Acta Pharm.
2021 Mar 01, 71, (1):33-56.
Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn's disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This (...)
see on pubmed
on Atopic Dermatitis
Enhanced Type 2 Immune Reactions by Increased IL-22/IL-22Ra1 Signaling in Chronic Rhinosinusitis With Nasal Polyps.
Allergy Asthma Immunol Res.
2020 Nov , 12, (6):980-993.
Recent studies have revealed the pathogenic role of interleukin (IL)-22 in atopic dermatitis and asthma. However, little is known about the role of IL-22 in the pathophysiology of chronic rhinosinusitis with nasal polyps. We aimed to investigate the expression of IL-22 and its pathogenic function in type 2 immune reactions of nasal polyps (NP).
see on pubmed
Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series.
Seok SH et al.
Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series.
Allergy Asthma Immunol Res.
2020 Nov , 12, (6):1063-1065.
Update on canine filaggrin: a review.
Combarros D et al.
Update on canine filaggrin: a review.
Vet Q.
2020 Dec , 40, (1):162-168.
Human filaggrin (FLG) plays a key role in epidermal barrier function, and loss-of-function mutations of its gene are primarily responsible for the development of human atopic dermatitis (AD). FLG expression is also reduced in the epidermis of atopic patients, due to the transcriptional effect of Th2 type cytokines. Canine atopic dermatitis (CAD) is a prevalent skin disease that shares many clinical and pathogenic features with its human homologue. The aim of this review is discuss current (...)
see on pubmed
